70 studies found for:
"Anaplastic oligoastrocytoma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
|
||||
| 2 | Recruiting |
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
|
||||
| 3 | Recruiting |
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
|
||||
| 4 | Recruiting |
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
|
||||
| 5 | Completed |
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
|
||||
| 6 | Active, not recruiting |
Sorafenib in Newly Diagnosed High Grade Glioma
|
||||
| 7 | Suspended |
Phase I/II Trial of the Safety, Tolerability, and Anti-tumor Efficacy of AXL1717 (Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
|
||||
| 8 | Recruiting |
A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
|
||||
| 9 | Active, not recruiting |
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
|
||||
| 10 | Recruiting |
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
|
||||
| 11 | Not yet recruiting |
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
|
||||
| 12 | Not yet recruiting |
Re-irradiation of High Grade Gliomas: a Quality of Life Study
|
||||
| 13 | Active, not recruiting |
BIBF 1120 for Recurrent High-Grade Gliomas
|
||||
| 14 | Recruiting |
A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
|
||||
| 15 | Recruiting |
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
|
||||
| 16 | Completed |
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
|
||||
| 17 | Active, not recruiting |
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
|
||||
| 18 | Suspended |
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
|
||||
| 19 | Recruiting |
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
|
||||
| 20 | Terminated |
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
|
† Indicates status has not been verified in more than two years
